Stay updated on ILIxadencel + CPI in Tumors Clinical Trial
Sign up to get notified when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.

Latest updates to the ILIxadencel + CPI in Tumors Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA site-wide NIH announcement about the website transition appears above the unchanged 403 error page. The site revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the previous study details with a generic error screen and a Home link. This prevents access to the trial information.SummaryDifference20%

- Check52 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0. This is a minor technical update and does not alter study details, eligibility criteria, or actions for participants.SummaryDifference0.1%

- Check66 days agoChange DetectedThe revision label on the page was updated from Revision: v3.6.5 to Revision: v3.6.6. This indicates a newer version of the page content.SummaryDifference0.1%

Stay in the know with updates to ILIxadencel + CPI in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.